Mogamulizumab and Ratio-Ipratropium Udv
Determining the interaction of Mogamulizumab and Ratio-Ipratropium Udv and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: Ipratropium inhalation, Ipratropium (Oral Inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-Ratio-Ketorolac
- Mogamulizumab-Ratio-Levobunolol
- Mogamulizumab-Ravicti
- Mogamulizumab-Ravicti Oral Liquid
- Mogamulizumab-Rayaldee
- Mogamulizumab-Rayos
- Ratio-Ipratropium Udv-Mogamulizumab-kpkc
- Ratio-Ipratropium Udv-Mogamulizumab-kpkc Intravenous
- Ratio-Ipratropium Udv-Molindone
- Ratio-Ipratropium Udv-Mometasone (Oral Inhalation)
- Ratio-Ipratropium Udv-Mometasone and Formoterol
- Ratio-Ipratropium Udv-Mometasone and formoterol Inhalation